Results 1 to 10 of about 10,636 (185)
Acute psychosis followed by fever: Malignant neuroleptic syndrome or viral encephalitis? [PDF]
Vojnosanitetski Pregled, 2014 Introduction. Neuroleptic malignant syndrome is rare, but potentially fatal idiosyncratic reaction to antipsychotic medications. It is sometimes difficult to diagnose some clinical cases as neuroleptic malignant syndrome and differentiate it ...
Stojanović Zvezdana, Špirić Željko
doaj +3 more sources
Neuroleptic malignant syndrome [PDF]
Arquivos de Neuro-Psiquiatria, 2011 Neuroleptic malignant syndrome (NMS) is a potentially fatal adverse event associated with the use of antipsychotics (AP). The objective of this study was to investigate the profile of cases of NMS and to compare our findings with those published in ...
Mariana Moscovich +7 more
doaj +4 more sources
Neuroleptic malignant syndrome
Journal of Family Medicine and Primary Care, 2016 Neuroleptic malignant syndrome (NMS) is a life-threatening emergency that is often seen as a complication of antipsychotic agents. It is characterized by a tetrad of motor, behavioral, autonomic, and laboratory abnormalities.
Bino Rajamani +2 more
doaj +3 more sources
Neuroleptic malignant syndrome [PDF]
Medical Journal of Australia, 1984 Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening complication of neuroleptic therapy. Its occurrence is not familiar to most emergency physicians. Early recognition and appropriate management of NMS may prevent significant morbidity and mortality.
G E, Irwin, J E, Simon
+14 more sources
Neuroleptic malignant syndrome [PDF]
British Journal of Psychiatry, 1992 The neuroleptic malignant syndrome (NMS) involves fever, extrapyramidal rigidity, and disturbances of autonomic function and consciousness. It occurs more often with high potency and depot forms, frequently 3 to 9 days after initiation and sometimes years later, and is not related to dose or ...
P, Simmons, E L, Marcus
+7 more sources
NEUROLEPTIC MALIGNANT SYNDROME
Journal of Psychosocial Nursing and Mental Health Services, 1986 The neuroleptic malignant syndrome (NMS) occurs as a hypersensitivity response in certain patients exposed to neuroleptics. It is a relatively rare, but potentially lethal complication, the incidence of which may have been underestimated. Recent interest in NMS has arisen due to the recognition that specific therapy may now be available.
J C, Masters, R, Spitler
+11 more sources
Neuroleptic malignant syndrome in clinical practices [PDF]
Hospital Pharmacology, 2016 Topic: Neuroleptic Malignant Syndrome is a rare but specific lethal reaction to neuroleptics / antipsychotics.It occurs in 0.02% to 3.3% of patients in the treatment applying conventional neuroleptic drugs.
Bugarinović Snežana M. +3 more
doaj +1 more source
SAGE Open Medical Case Reports, 2022 Neuroleptic malignant syndrome is a rare, fatal antipsychotic-induced idiosyncratic reaction characterised by hyperthermia, altered consciousness, autonomic instability and rigidity with elevated creatine kinase levels and leukocytosis.
Siddiqa Ozaal, Gaya Katulanda
doaj +1 more source
Heliyon, 2020 Neuroleptic malignant syndrome is a rare but life-threatening disorder associated with the use of neuroleptic drugs, and is characterized by fever, altered mental status, muscle rigidity, autonomic instability, myoclonus, elevated creatine kinase levels,
Kazunori Fukushima +9 more
doaj +1 more source
Diagnosis and Treatment of Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report
Acta Médica Portuguesa, 2021 Neuroleptic malignant syndrome is a neurological emergency caused by dysregulation of dopaminergic neurotransmission. While it is typically characterized by muscle rigidity, fever and altered mental status, it may have a heterogeneous and non-specific ...
Ana Maia +3 more
doaj +1 more source